First Myanmar Investment Pharma
Фармацевтическое производство FMI Group по производству непатентованных лекарств и товаров медицинского назначения.
Фармацевтическая дочерняя компания First Myanmar Investment производит непатентованные фармацевтические продукты и пищевые добавки для внутреннего распространения. Он распространяется через больничные цепочки поставок и розничные аптечные сети.
- Type
- brand seeking distribution
- Location
- Yangon, Myanmar
- Founded
- 2012
- Website
- https://www.fmi.com.mm
- Categories
- Медицинские товары и расходники
- Markets
- Мьянма (Бирма)
Verified facts
- web-presence-since (green), checked 2026-08-08 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)